NCT02735187View on ClinicalTrials.gov

Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Psoriasis Vulgaris
Interventions
DEVICE

Blue light treatment

Phototherapy of localized psoriasis vulgaris plaque with a wearable device emitting blue light at 453nm.

DRUG

Vitamin D

Treatment of contralateral localized psoriasis vulgaris plaque with Vitamin D creme (Daivonex)

Trial Locations (1)

52074

Department of Dermatology and Allergology, Medical faculty of the RWTH Aachen, Aachen

All Listed Sponsors
lead

Philips Electronics Nederland BV

INDUSTRY

NCT02735187 - Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D. | Biotech Hunter | Biotech Hunter